Venture
Evommune, Inc.
Latest Form D 2025-01-08- CIK 2044725
- State CA
- Other
- 4 Form D offerings since 2025-01-07
- Total sold
- $267M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2025-01-07
- Latest round
- $115M
- 2025-01-08 · 021-534546
- Investors
- 25
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-01-08 · $115M
- 2025-01-07$12.5M021-534380
- 2025-01-08$81.8M021-534510
- 2025-01-08$57.5M021-534516
- 2025-01-08$115M021-534546
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($115M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-534546 | First filed2025-01-08 | Latest2025-01-08 | Sought$115M | Sold$115M | Investors25 | Exemptions506(b) |
| 021-534516 | First filed2025-01-08 | Latest2025-01-08 | Sought$57.5M | Sold$57.5M | Investors16 | Exemptions506(b) |
| 021-534510 | First filed2025-01-08 | Latest2025-01-08 | Sought$84.4M | Sold$81.8M | Investors10 | Exemptions506(b) |
| 021-534380 | First filed2025-01-07 | Latest2025-01-07 | Sought$12.5M | Sold$12.5M | Investors18 | Exemptions506(b) |
Who backs Evommune, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-01-08
| Name | Relationship |
|---|---|
| Luis Pena | RelationshipExecutive Officer, Director |
| Eugene Bauer | RelationshipExecutive Officer, Director |
| Robert Hopfner | RelationshipDirector |
| Yuexin Yu | RelationshipDirector |
| Felice Verduyn-van Weegen | RelationshipDirector |
| Derek DiRocco | RelationshipDirector |
| Francois Beaubien | RelationshipDirector |
| Benjamin McGraw | RelationshipDirector |
| David Cohen | RelationshipDirector |
| Kyle Carver | RelationshipExecutive Officer |
| Gregory Moss | RelationshipExecutive Officer |
| Jeegar Patel | RelationshipExecutive Officer |
| Janice Drew | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2025-01-07
- Latest filing
- 2025-01-08
Who backs Evommune, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗